Skip to main content

Advertisement

SpringerLink
Log in

Primary intraocular lymphoma: a review

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Primary intraocular lymphoma (PIOL) is a rare, non-Hodgkin lymphoma considered to be a subtype of primary central nervous system lymphoma. We describe a 65-year-old woman who presented to the Hematology/Oncology Clinic at Scripps Clinic, La Jolla, California, who was diagnosed with bilateral PIOL without systemic disease. She enjoyed a 16-month remission but ultimately recurred in the brain. We reviewed the literature and present a discussion of the diagnostic criteria for PIOL and current strategies for treating PIOL in immunocompetent patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Pe’er J, Hochberg FH, Foster CS (2009) Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17:299–306

    Article  PubMed  Google Scholar 

  2. Levy-Clarke GA, Chan CC, Nussenblatt RB (2005) Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19:739–749 viii

    Article  PubMed  Google Scholar 

  3. Coupland SE, Heimann H, Bechrakis NE (2004) Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 242:901–913

    Article  PubMed  Google Scholar 

  4. Bardenstein DS (1998) Intraocular lymphoma. Cancer Control 5:317–325

    PubMed  Google Scholar 

  5. Hormigo A, Abrey L, Heinemann MH, DeAngelis LM (2004) Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 126:202–208

    Article  PubMed  Google Scholar 

  6. Choi JY, Kafkala C, Foster CS (2006) Primary intraocular lymphoma: a review. Semin Ophthalmol 21:125–133

    Article  PubMed  Google Scholar 

  7. Faia LJ, Chan CC (2009) Primary intraocular lymphoma. Arch Pathol Lab Med 133:1228–1232

    PubMed  CAS  Google Scholar 

  8. Sen HN, Bodaghi B, Hoang PL, Nussenblatt R (2009) Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm 17:133–141

    Article  PubMed  CAS  Google Scholar 

  9. Raparia K, Chang CC, Chevez-Barrios P (2009) Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens. Arch Pathol Lab Med 133:1233–1237

    PubMed  Google Scholar 

  10. Kim SK, Chan CC, Wallace DJ (2005) Management of primary intraocular lymphoma. Curr Oncol Rep 7:74–79

    Article  PubMed  Google Scholar 

  11. Margolis L, Fraser R, Lichter A, Char DH (1980) The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 45:688–692

    Article  PubMed  CAS  Google Scholar 

  12. Chan CC, Wallace DJ (2004) Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285–295

    PubMed  Google Scholar 

  13. Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T (1986) Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 57:1273–1275

    Article  PubMed  CAS  Google Scholar 

  14. Strauchen JA, Dalton J, Friedman AH (1989) Chemotherapy in the management of intraocular lymphoma. Cancer 63:1918–1921

    Article  PubMed  CAS  Google Scholar 

  15. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711–715

    PubMed  CAS  Google Scholar 

  16. Batchelor T, Carson K, O’Neill A, Grossman SA, Alavi J, New P, Hochberg F, Priet R (2003) Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 21:1044–1049

    Article  PubMed  CAS  Google Scholar 

  17. Ferreri AJ, Blay JY, Reni M, Pasini F, Gubkin A, Tirelli U, Calderoni A, Zucca E, Cortelazzo S, Chassagne C, Tinguely M, Borisch B, Berger F, Ponzoni M, Cavalli F (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol 13:531–538

    Article  PubMed  CAS  Google Scholar 

  18. Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730–4735

    Article  PubMed  CAS  Google Scholar 

  19. de Smet MD, Stark-Vancs V, Kohler DR, Smith J, Wittes R, Nussenblatt RB (1996) Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol 121:442–444

    PubMed  Google Scholar 

  20. Mason JO, Fischer DH (2003) Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma. Ophthalmology 110:1241–1244

    Article  PubMed  Google Scholar 

  21. Sandor V, Stark-Vancs V, Pearson D, Nussenblat R, Whitcup SM, Brouwers P, Patronas N, Heiss J, Jaffe E, deSmet M, Kohler D, Simon R, Wittes R (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16:3000–3006

    PubMed  CAS  Google Scholar 

  22. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA (1997) Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115:1152–1156

    PubMed  CAS  Google Scholar 

  23. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, Pe’er J (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709–1716

    Article  PubMed  Google Scholar 

  24. Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ, Donaldson MJ, O’Neill BP, Johnston PB, Johnson KM, Dixon LE, Salomao DR, Cameron JD (2007) Intraocular use of rituximab. Eye (Lond) 21:1524–1527

    Article  CAS  Google Scholar 

  25. Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742–749

    PubMed  CAS  Google Scholar 

  26. Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, Casasnovas O, Dupriez B, Souleau B, Taksin AL, Gisselbrecht C, Jaccard A, Omuro A, Sanson M, Janvier M, Kolb B, Zini JM, Leblond V (2008) Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire. J Clin Oncol 26:2512–2518

    Article  PubMed  Google Scholar 

  27. Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM (2003) Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. J Clin Oncol 21:4151–4156

    Article  PubMed  CAS  Google Scholar 

  28. van Oers MH, Van Glabbeke M, Giurgea L, Klasa R, Marcus RE, Wolf M, Kimby E, van t Veer M, Vranovsky A, Holte H, Hagenbeek A (2098) Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin’s lymphoma: long-term outcome of the EORTC. 1 phase III randomized intergroup study. J Clin Oncol 28:2853–2858

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Scripps Clinic, 10666 N. Torrey Pines Road, La Jolla, CA, 92037, USA

    Gregory S. Vosganian & Alan Saven

  2. Division of Hematopathology, Scripps Clinic, La Jolla, CA, USA

    Saskia Boisot & Robert W. Sharpe

  3. The Division of Ophthalmology, Shiley Eye Center/Jacobs Retina Center, University of California-San Diego, La Jolla, CA, USA

    Kathrin I. Hartmann & William R. Freeman

  4. Division of Radiation/Oncology, Scripps Clinic and Green Hospital, La Jolla, CA, USA

    Prabhakar Tripuraneni

Authors
  1. Gregory S. Vosganian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saskia Boisot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathrin I. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William R. Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert W. Sharpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prabhakar Tripuraneni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alan Saven
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory S. Vosganian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vosganian, G.S., Boisot, S., Hartmann, K.I. et al. Primary intraocular lymphoma: a review. J Neurooncol 105, 127–134 (2011). https://doi.org/10.1007/s11060-011-0618-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0618-1

Keywords

Search

Navigation